COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #46 of 63
1/6 Prophylaxis study
Hirsch et al., Microbiology & Infectious Diseases (Peer Reviewed)
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation
Source   PDF   Share   Tweet
Report on ivermectin prophylaxis for healthcare workers in a hospital in Argentina, showing 0 cases in the 162 participants. Dosage was 0.2mg/kg weekly for eight weeks, followed by 4 months rest.

Hirsch et al., 1/6/2021, peer-reviewed, 2 authors.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit